Immucor Inc is categorized under Blood Derivative Diagnostic Agents in Norcross, GA and active since 2011.
Immucor Inc was established in 2011, and today employs 1 to 4, earning Unknown per year. This is a Blood Derivative Diagnostic Agents business, which does work in the B2B market, and is classified as a Blood Derivative Diagnostic Agents, under code number 3254140 by the NAICS.
If you are seeking more information, feel free to contact William Hawkins, Chief Executive Officer at the company’s headquarters by writing to 3130 Gateway Drive, Norcross, Georgia GA 30071 or by phoning (770) 441-2051. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Immucor Inc |
| Contact Person: | William Hawkins, Chief Executive Officer |
| Address: | 3130 Gateway Drive, Norcross, Georgia 30071 |
| Phone Number: | (770) 441-2051 |
| Website Address: | immucor.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2011 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Blood Derivative Diagnostic Agents |
| SIC Code: | 2835 |
| NAICS Code: | 3254140 |
| Share This Business: |
Immucor Inc was started in 2011 to provide professional Blood Derivative Diagnostic Agents under the SIC code 2835 and NAICS code 3254140. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact William Hawkins, Chief Executive Officer for inquiries that concern Immucor Inc by calling the company number (770) 441-2051, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Immucor Inc can be found at the coordinates 33.93245,-84.25811 as well as the street address 3130 Gateway Drive in Norcross, Georgia 30071.
For its online presence, you may visit Immucor Inc’s website at immucor.com and engage with its social media outlets through on Twitter and on Facebook.